The FX futures market has long intrigued the traditional OTC trader, viewing it as an interesting parallel marketplace, but without a clear understanding about why or how they should participate in it. Yet over the last few years the growing trend of futures adoption has arguably become too big to ignore.

2025 was a record-breaking year for our FX futures suite, with growth across almost every key metric like record open interest, the number of large open interest holders and positioning from asset managers. Crucially, this expansion welcomed over 130 new clients who were first-ever FX futures traders. This growth story is underpinned by a range of catalysts, including potential balance sheet optimization for banks, margin and tax efficiencies[1], and the removal of the need for ISDAs or bilateral credit lines to trade.

Asset manager gross notional in FX futures

Absolute numbers also illustrate the size of the market behind these records. Throughout 2025, over 1,000 firms were active in our FX futures market, with over $43 trillion cleared, more than 50 currency pairs supported (>20 of which are non-USD crosses), average daily volumes of $85.7 billion and a single day high of over $292 billion.[2]

The large majority of this activity is enabled by the robust and deep liquidity available in our central limit order book (CLOB), which is widely accepted to be a foundational source of market price discovery and risk transfer across a range of currencies, including all of the G7 pairs and the Mexican peso. Key developments have, however, taken place to further connect the futures CLOB to the OTC market, which are vital for the continuation of this growth trajectory.

Marrying the OTC market with FX futures

As the FX futures market continues to grow, so does client demand to more closely align it with the OTC market. Recent enhancements to our FX futures market include the addition of new currency pairs with SGD, THB and IDR added in 2025, and the provision of regionally relevant snapshots for daily valuations, including 4:00 p.m. London, 4:00 p.m. New York and 3:00 p.m. Tokyo time. Yet the ability to truly bridge the OTC and FX futures markets is arguably the most important development for the overall efficacy of the market to be a truly viable venue for both OTC traders and futures traders, and we have made a concerted effort on three key initiatives to achieve this.

EFRPs

EFRPs[3] allow clients to trade in an OTC manner and lean on OTC liquidity while holding a centrally cleared FX futures contract at the end of the transaction. Two similar, but distinct workflows, exist: one that allows existing OTC trades to be backloaded or novated into cleared futures, and the other that allows clients to trade on OTC liquidity but immediately hold the resulting position as a centrally cleared FX futures. 

Volumes in EFRPs grew +197% year-on-year, with activity in 2025 across over 30 currency pairs. Multiple banks now provide fully automated front-to-back workflows alongside “high touch” voice workflows for clients preferring that mechanism.

Average daily volume (USD-equivalent notional) in FX EFRPs

FX Link and FX Spot+ are two “on screen” marketplaces that directly and atomically link the OTC spot market with our FX futures market. 

FX Link provides a firm, no-last-look price for FX swaps risk - with an OTC spot FX transaction as the near leg and FX futures as the far leg. This marketplace enables traders to either seamlessly move risk from spot to futures or vice versa. It’s a critical tool for liquidity providers to optimize their funding costs while providing STIR traders truly firm pricing for FX swaps, with liquidity separated from credit, which doesn’t exist anywhere else in the market. 

FX Spot+ is the newest addition to our FX ecosystem, allowing a resting order in the futures market to be displayed and traded as a spot order, and in reverse allowing an OTC trader to rest a spot order and have that displayed to the entirety of the more than 1,000 firms active in the FX futures market. 

This unique new marketplace was specifically designed for OTC traders to have the ability to access the deep and complementary pool of FX futures liquidity while viewing, trading, booking and settling transactions in OTC spot format. Now OTC traders can distribute their spot liquidity to the very large and hugely diverse ecosystem of FX futures traders. 

Since its launch, FX Spot+ has seen single trading days exceeding $8 billion. Over 60 firms have traded, including 35 banks that were previously not participants in the FX futures market.

FX Spot+ and FX Link are two clear examples of how our initiatives are bringing the FX market together like never before.  

The bottom line

Our expansive and growing futures marketplace offers diverse use cases and has become more accessible than ever. Today, with multiple transactional methods ensuring seamless integration, clients can comfortably manage their FX risk. Our ambition is for OTC FX and FX futures to be a "marriage made in heaven," moving beyond their discrete identities and becoming a new market reality.

Footnotes

[1] CME Group Inc. and its affiliates do not provide tax, legal or accounting advice. This material has been prepared for informational purposes only, and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. You should consult your own tax, legal and accounting advisors before engaging in any transaction.

[2] All data from 2025 trading activity and supplied by CME Group. 

[3] EFRPs are subject to Rule 538.


Disclaimer

Exchange traded derivatives and cleared over-the-counter (“OTC”) derivatives are not suitable for all investors and involve the risk of loss. Exchange traded and OTC derivatives are leveraged instruments and because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money initially deposited. This communication does not (within the meaning of any applicable legislation) constitute a Prospectus or a public offering of securities; nor is it a recommendation, offer, invitation or solicitation to buy, sell or retain any specific investment or service.

The content in this communication has been compiled by CME Group for general purposes only and is not intended to provide, and should not be construed as advice. It does not take into account your objectives, financial situation or needs, and you should obtain appropriate professional advice before acting on or relying on the information set out in this communication. Although every attempt has been made to ensure the accuracy of the information within this communication as of the date of publication, CME Group assumes no responsibility for any errors or omissions and will not update it. Additionally, all examples and information in this communication are used for explanation purposes only and should not be considered, investment advice, the results of actual market experience, or the promotion of any particular products or services.  All matters pertaining to rules and specifications herein are made subject to and superseded by official Chicago Mercantile Exchange Inc. (“CME”), the Chicago Board of Trade, Inc. (“CBOT”), the New York Mercantile Exchange, Inc. (“NYMEX”), and the Commodity Exchange, Inc. (“COMEX”) rulebooks or, as applicable, the respective Rulebooks of CME Group’s certain other subsidiary trading facilities. Current rules should be consulted in all cases including matters relevant to contract specifications.

CME Group does not represent that any material or information contained in this communication is appropriate for use or permitted in any jurisdiction or country where such use or distribution would be contrary to any applicable law or regulation. This communication has not been reviewed or approved by any regulatory authority and access shall be at the liability of the user.

In Australia, each of Chicago Mercantile Exchange Inc. (ARBN 103 432 391), Board of Trade of the City of Chicago Inc. (ARBN 110 594 459), New York Mercantile Exchange, Inc. (ARBN 113 929 436) and Commodity Exchange, Inc. (ARBN 622 016 193) is a registered foreign company in Australia and holds an Australian market licence.

In Hong Kong, CME, CBOT, NYMEX and COMEX are authorized by the Hong Kong Securities and Futures Commission (the "SFC") to provide Automated Trading Services ("ATS") via the CME GLOBEX system, and CME is authorized by the SFC to provide ATS via the CME Clearing System, under Part III of the Securities and Futures Ordinance (the "SFO").

In Japan, CME has a Foreign Clearing Organisation (FCO) license under the Financial Instruments and Exchange Act of Japan.

In Singapore, CME, CBOT, NYMEX and COMEX are regulated as a recognized market operator and CME is regulated as a recognized clearing house under the Securities and Futures Act (Chapter 289) ("SFA"). Save as aforesaid, none of the CME Group entities are licensed to carry on regulated activities under the SFA or to provide financial advisory services under the Financial Advisers Act (Chapter 110) in Singapore.

None of CME Group entities are registered or licensed to provide, nor does it purport to provide, financial services of any kind in some jurisdictions, including, but not limited to, India, Korea, Malaysia, New Zealand, People’s Republic of China, Philippines, Thailand, and Vietnam and in any jurisdiction where CME Group is not authorized to do business or where such distribution would be contrary to the local laws and regulations.

You are advised to exercise caution in relation to the information contained herein. If you are in any doubt about any of the contents of this communication, you should obtain independent professional advice. 

In Hong Kong, CME Group is not licensed to carry on business in dealing or advising on futures contracts under the SFO. This communication is for distribution in Hong Kong solely to corporations licensed by the SFC under Part V or authorized under Part III of the SFO.

In Japan, this communication is for distribution solely to certain qualified sophisticated investors as set forth in the Commodities Futures Act of Japan (Law No. 239 of 1950, as amended) and the related rules, as appropriate. Other than that, the information contained in this communication is not directed at any person in Japan and is not intended for marketing or soliciting Japanese customers to trade or use any specific CME products or services.

In the Republic of Korea, this communication is for distribution solely to “professional investors” (as defined in Article 9(5) of the Financial Investment Services and Capital Markets Act and related rules) in response to a request from such professional investors or through a licensed investment broker.

In the People’s Republic of China, this communication is provided to the reader only and shall not be copied or redistributed within the People’s Republic of China for any other purpose. No information contained in this communication constitutes or leads to an offer to provide or sell any financial service or product, a recommendation (express or implied) to take any action in respect of any financial product, or any investment advice or market forecast.

This communication is for distribution in Singapore solely to certain institutional investors (such as persons holding a capital markets services licence for trading in futures contracts or exempt from such requirements under the SFA), to accredited investors and to expert investors (each as defined in the SFA).

In Vietnam, Vietnam residents may be subject to certain statutory conditions for trading on offshore platforms such as CME, CBOT, NYMEX and COMEX and not all products on CME, CBOT, NYMEX and COMEX may be permissible for trading by Vietnam residents. Investors in Vietnam are responsible for ensuring that their trades on CME, CBOT, NYMEX and COMEX are compliant with all relevant laws applicable to them.

CME Group, the Globe Logo, CME, Globex, E-Mini, CME Direct, CME DataMine and Chicago Mercantile Exchange are trademarks of Chicago Mercantile Exchange Inc.  CBOT and the Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago, Inc.  NYMEX and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc.

BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.

Certain CME Group subsidiaries are authorised and regulated by regulatory authorities. Certain of those subsidiaries are required to retain records of telephone conversations and other electronic communications for a period of 5 to 7 years where required by certain regulation, copies of which are available on request (which may be subject to a fee). For further regulatory information please see www.cmegroup.com.

Copyright © 2026 CME Group Inc. All rights reserved.
Mailing Address: 20 South Wacker Drive, Chicago, Illinois 60606

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2026 CME Group Inc. All rights reserved.